Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XOMO | 11.43 | 0.17 | +1.51% |
| YieldMax XOM Option Income Strategy ETF (XOMO) | |||
| UJB | 73.77 | N/A | N/A |
| ProShares Ultra High Yield (UJB) | |||
| GUSA | 67.10 | N/A | N/A |
| Goldman Sachs MarketBeta U.S. 1000 Equity ETF (GUSA) | |||
| TDAQ | 26.87 | -0.57 | -2.08% |
| TappAlpha Innovation 100 Growth & Daily Income ETF (TDAQ) | |||
| IAF | 12.37 | -0.27 | -2.14% |
| abrdn Australia Equity Fund | |||
Industry Biotechnology